tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RPRX Stock Latest News

Royalty Pharma price target raised to $42 from $40 at Citi
The FlyRoyalty Pharma price target raised to $42 from $40 at Citi
5d ago
RPRX
Royalty Pharma Strengthens Board with New Appointments
PremiumCompany Announcements
Royalty Pharma Strengthens Board with New Appointments
10d ago
8K
RPRX
Royalty Pharma appoints Ho, Weatherman to board of directors
PremiumThe Fly
Royalty Pharma appoints Ho, Weatherman to board of directors
10d ago
DNLI
RPRX
Royalty Pharma price target raised to $54 from $51 at Morgan Stanley
PremiumThe Fly
Royalty Pharma price target raised to $54 from $51 at Morgan Stanley
17d ago
RPRX
Strategic Financial Agreements and Promising Drug Developments Justify Buy Rating for Royalty Pharma
PremiumRatings
Strategic Financial Agreements and Promising Drug Developments Justify Buy Rating for Royalty Pharma
1M ago
RPRX
Royalty Pharma’s Strategic Partnership with Revolution Medicines: A High-Reward Investment Opportunity
PremiumRatingsRoyalty Pharma’s Strategic Partnership with Revolution Medicines: A High-Reward Investment Opportunity
1M ago
RPRX
Royalty Pharma announces $2B funding arrangement with Revolution Medicines
Premium
The Fly
Royalty Pharma announces $2B funding arrangement with Revolution Medicines
1M ago
RPRX
RVMD
Revolution Medicines enters $2B funding agreement with Royalty Pharma
Premium
The Fly
Revolution Medicines enters $2B funding agreement with Royalty Pharma
1M ago
RPRX
RVMD
Royalty Pharma 12M share Spot Secondary priced at $33.25
PremiumThe Fly
Royalty Pharma 12M share Spot Secondary priced at $33.25
2M ago
RPRX
Royalty Pharma Completes Major Acquisition and Restructuring
PremiumCompany Announcements
Royalty Pharma Completes Major Acquisition and Restructuring
2M ago
8K
RPRX
Charter upgraded, Cisco downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Charter upgraded, Cisco downgraded: Wall Street’s top analyst calls
2M ago
FL
CAT
Royalty Pharma resumed with an Overweight at Morgan Stanley
PremiumThe Fly
Royalty Pharma resumed with an Overweight at Morgan Stanley
2M ago
RPRX
Royalty Pharma’s Annual General Meeting Highlights
PremiumCompany AnnouncementsRoyalty Pharma’s Annual General Meeting Highlights
3M ago
8K
RPRX
Royalty Pharma Reports Strong Q1 2025 Growth
Premium
Company Announcements
Royalty Pharma Reports Strong Q1 2025 Growth
3M ago
RPRX
Royalty Pharma’s Earnings Call: Growth and Optimism
Premium
Company Announcements
Royalty Pharma’s Earnings Call: Growth and Optimism
3M ago
RPRX
Royalty Pharma reports Q1 portfolio receipts of $839M
PremiumThe Fly
Royalty Pharma reports Q1 portfolio receipts of $839M
3M ago
RPRX
Royalty Pharma sees FY25 portfolio receipts $2.975B-$3.125B
PremiumThe Fly
Royalty Pharma sees FY25 portfolio receipts $2.975B-$3.125B
3M ago
RPRX
Royalty Pharma price target raised to $42 from $41 at BofA
PremiumThe Fly
Royalty Pharma price target raised to $42 from $41 at BofA
3M ago
RPRX
Royalty Pharma Appoints Dr. Vlad Coric to Board
PremiumCompany Announcements
Royalty Pharma Appoints Dr. Vlad Coric to Board
4M ago
8K
RPRX
Royalty Pharma appoints Biohaven CEO Vlad Coric to board
PremiumThe FlyRoyalty Pharma appoints Biohaven CEO Vlad Coric to board
4M ago
BHVN
RPRX
Royalty Pharma pullback a buying opportunity, says Citi
Premium
The Fly
Royalty Pharma pullback a buying opportunity, says Citi
4M ago
RPRX
Royalty Pharma’s Strong Portfolio and Future Growth Potential Underpin Buy Rating
Premium
Ratings
Royalty Pharma’s Strong Portfolio and Future Growth Potential Underpin Buy Rating
5M ago
RPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >